Literature DB >> 29336707

Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016.

Yogesh K Gurav1, Pragya D Yadav1, Mangesh D Gokhale1, Tushar R Chiplunkar2, Rajlakshmi Vishwanathan1, Deepak Y Patil1, Rajlaxmi Jain1, Anita M Shete1, Savita L Patil1, G D Sarang3, Gajanan N Sapkal1, M D Andhare3, Y R Sale4, Pradeep S Awate5, Devendra T Mourya1.   

Abstract

INTRODUCTION: Kyasanur forest disease (KFD) outbreak was confirmed in Dodamarg Taluka, Sindhudurga district (Maharashtra) in India during the year 2016. The rise in suspected KFD cases was reported in January 2016, peaked during March, and then declined gradually from April 2016. The outbreak was thoroughly investigated considering different socio-clinical parameters.
METHODS: Total, 488 suspected KFD cases were investigated using KFD specific real-time RT-PCR and anti-KFDV IgM enzyme-linked immunosorbent assay (ELISA). Sero-epidemiological survey was carried out in the affected area using anti-KFDV IgG ELISA.
RESULTS: Among suspected KFD cases, high age-specific attack rate (105.1 per 1000 persons) was observed in adults (aged 40-59 years). Out of 488 suspected KFD cases, 130 were laboratory confirmed. Of these, 54 cases were KFDV real-time RT-PCR positive, 66 cases were anti-KFDV IgM ELISA positive and 10 cases were positive by both the assays. Case fatality ratio among laboratory-confirmed KFD cases were 2.3% (3/130). Majority of laboratory-confirmed KFD cases (93.1%) had visited Western Ghats forest in Dodamarg for activities like working in cashew nut farms (79.8%), cashew nut fruit collection (76.6%), collection of firewood (68.5%) and dry leaves/grass (40.3%), etc., before the start of symptoms. Common clinical features included fever (100%), headache (93.1%), weakness (84.6%), and myalgia (83.1%). Hemorrhagic manifestations were observed in nearly one-third of the laboratory-confirmed KFD cases (28.5%). A seroprevalence of (9.7%, 72/745) was recorded in KFD-affected area and two neighboring villages (9.1%, 15/165). Serosurvey conducted in Ker village showed clinical to subclinical ratio of 6:1 in KFD-affected areas.
CONCLUSION: This study confirms the outbreak of KFD Sindhudurg district with 130 cases. Detection of anti-KFDV IgG antibodies among the healthy population in KFD-affected area during the KFD outbreak suggested the past exposure of KFD infection. This outbreak investigation has helped health authorities in adopting KFD vaccination strategy for the population at risk.

Entities:  

Keywords:  IgM ELISA; Kyasanur forest disease; Maharashtra; real-time RT-PCR; seroprevalence

Mesh:

Substances:

Year:  2018        PMID: 29336707     DOI: 10.1089/vbz.2017.2129

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  10 in total

Review 1.  Emerging and re-emerging viral infections in India.

Authors:  Mamta Patel; Akhil Dhanesh Goel; Pankaj Bhardwaj; Nitin Joshi; Nitesh Kumar; Manoj Kumar Gupta; Vidhi Jain; Suman Saurabh; Kamlesh Patel
Journal:  J Prev Med Hyg       Date:  2021-09-15

Review 2.  Historical Expansion of Kyasanur Forest Disease in India From 1957 to 2017: A Retrospective Analysis.

Authors:  S Chakraborty; F C D Andrade; S Ghosh; J Uelmen; M O Ruiz
Journal:  Geohealth       Date:  2019-02-05

3.  Predicting disease risk areas through co-production of spatial models: The example of Kyasanur Forest Disease in India's forest landscapes.

Authors:  Bethan V Purse; Narayanaswamy Darshan; Gudadappa S Kasabi; France Gerard; Abhishek Samrat; Charles George; Abi T Vanak; Meera Oommen; Mujeeb Rahman; Sarah J Burthe; Juliette C Young; Prashanth N Srinivas; Stefanie M Schäfer; Peter A Henrys; Vijay K Sandhya; M Mudassar Chanda; Manoj V Murhekar; Subhash L Hoti; Shivani K Kiran
Journal:  PLoS Negl Trop Dis       Date:  2020-04-07

4.  Geospatial clustering, seasonal trend and forecasting of Kyasanur Forest Disease in the state of Goa, India, 2015-2018.

Authors:  Annet Oliveira; Kalaiselvi Selvaraj; Jaya Prasad Tripathy; Utkarsh Betodkar; Jagadish Cacodcar; Nikhita Quadros; Abhijit Wadkar
Journal:  Trop Med Health       Date:  2020-04-28

5.  Phylogeography of Kyasanur Forest Disease virus in India (1957-2017) reveals evolution and spread in the Western Ghats region.

Authors:  Pragya D Yadav; Savita Patil; Santoshkumar M Jadhav; Dimpal A Nyayanit; Vimal Kumar; Shilpi Jain; Jagadish Sampath; Devendra T Mourya; Sarah S Cherian
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

6.  'None of my ancestors ever discussed this disease before!' How disease information shapes adaptive capacity of marginalised rural populations in India.

Authors:  Festus A Asaaga; Mujeeb Rahman; Suresh D Kalegowda; Jagadeesh Mathapati; Irfanahemad Savanur; Prashanth N Srinivas; Tanya Seshadri; Darshan Narayanswamy; Shivani K Kiran; Meera A Oommen; Juliette C Young; Bethan V Purse
Journal:  PLoS Negl Trop Dis       Date:  2021-03-11

7.  Clinical and Laboratory Diagnostic Features of Kyasanur Forest Disease: A Study From Wayanad, South India.

Authors:  Vineeth Gladson; Hisham Moosan; Sheela Mathew; Dineesh P
Journal:  Cureus       Date:  2021-12-06

Review 8.  Clinical & epidemiological significance of Kyasanur forest disease.

Authors:  Ashok Munivenkatappa; Rima Rakesh Sahay; Pragya D Yadav; Rajalakshmi Viswanathan; Devendra T Mourya
Journal:  Indian J Med Res       Date:  2018-08       Impact factor: 2.375

9.  Kinetics of viral RNA, immunoglobulin-M & G antibodies in Kyasanur forest disease.

Authors:  Pragya D Yadav; Yogesh K Gurav; Anita M Shete; Rajlaxmi Jain; Dimpal A Nyayanit; Prachi G Pardeshi; Rajlakshmi Viswanathan; Tushar R Chiplunkar; Pradip Awate; Triparna P Majumdar; Rima R Sahay; Devendra T Mourya
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

Review 10.  Reviewing the ecological evidence base for management of emerging tropical zoonoses: Kyasanur Forest Disease in India as a case study.

Authors:  Sarah J Burthe; Stefanie M Schäfer; Festus A Asaaga; Natrajan Balakrishnan; Mohammed Mudasssar Chanda; Narayanaswamy Darshan; Subhash L Hoti; Shivani K Kiran; Tanya Seshadri; Prashanth N Srinivas; Abi T Vanak; Bethan V Purse
Journal:  PLoS Negl Trop Dis       Date:  2021-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.